Ophthalmic Biophysics, L V Prasad Eye Institute, Hyderabad, India.
School of Medical Sciences, University of Hyderabad, Hyderabad, India.
Cornea. 2021 May 1;40(5):571-577. doi: 10.1097/ICO.0000000000002499.
Xeroderma pigmentosum (XP) is an extreme hypersensitivity to sunlight causing skin freckling and pigmentary changes because of defective DNA repair mechanisms. The purpose of this article is to evaluate the spectrum of ocular and systemic features in XP at a tertiary eye care center in India over 32 years.
Data from 418 eyes of 209 patients diagnosed with XP from 1987 to 2018 were reviewed retrospectively for demographics, complaints, ocular features, systemic associations, and their management.
Median age at diagnosis was 2 years (interquartile range, 0.5-5 years). A total of 124 patients (59.3%) were men. There was parental consanguinity in 74.4% cases. Common ocular complaints were photophobia (47.1%), ocular discomfort (45%), defective vision (36.6%), redness (13.4%), tissue growth (12%), white spot (11.2%), and pain (10.5%). At presentation, 43.5% had corneal scars (45.5% were located inferiorly and 70.9% covered visual axis). Corneal vascularization and limbal stem cell deficiency were noted in 37.4%. A total of 56% of patients had at least 1 tumor, and 6.7% had neurological abnormalities. At least 1 ocular surgery was performed in 37.8% of patients. Ophthalmic surgical interventions included tumor excision (23%), keratoplasty (13.4%), and nontumor ocular surface surgery (3.4%).
XP is a disorder that has high ocular morbidity in Indian patients. The recognition of common signs and symptoms and relative frequency of various ocular complications with time trends will help in managing and reducing the sequelae of this otherwise untreatable and progressive disease.
着色性干皮病(XP)是一种对阳光极度过敏的疾病,由于 DNA 修复机制缺陷,导致皮肤出现雀斑和色素变化。本文的目的是在印度的一家三级眼科护理中心评估 XP 的眼部和全身特征谱,时间跨度为 32 年。
回顾性分析 1987 年至 2018 年间在该中心被诊断为 XP 的 209 例患者的 418 只眼的人口统计学资料、主诉、眼部特征、全身关联及其治疗情况。
中位诊断年龄为 2 岁(四分位距,0.5-5 岁)。共 124 例(59.3%)为男性。74.4%的患者有近亲结婚史。常见的眼部主诉包括畏光(47.1%)、眼部不适(45%)、视力障碍(36.6%)、眼红(13.4%)、组织生长(12%)、白点(11.2%)和疼痛(10.5%)。就诊时,43.5%的患者有角膜瘢痕(45.5%位于下方,70.9%覆盖视轴)。37.4%的患者有角膜血管化和角膜缘干细胞缺乏。共有 56%的患者至少有 1 个肿瘤,6.7%的患者有神经异常。37.8%的患者至少进行了 1 次眼部手术。眼科手术干预包括肿瘤切除术(23%)、角膜移植术(13.4%)和非肿瘤性眼表手术(3.4%)。
XP 是一种在印度患者中具有高眼部发病率的疾病。认识常见的体征和症状以及各种眼部并发症的相对频率及其随时间的变化趋势,将有助于管理和减少这种 otherwiseuntreatable 和进行性疾病的后遗症。